Literature DB >> 12383190

Time course of bleomycin-induced lung fibrosis.

G Izbicki1, M J Segel, T G Christensen, M W Conner, R Breuer.   

Abstract

Intratracheal instillation (IT) of bleomycin is a widely used experimental model for lung fibrosis. In this study we describe the time-course of bleomycin-induced lung fibrosis in mice using computer-assisted morphometry. C57Bl/6J mice were treated with a single IT dose of bleomycin or control saline. Animals were killed 3, 6, 14 and 21 days post-IT. Lung injury was evaluated by analysis of bronchoalveolar lavage (BAL) fluid, hydroxyproline concentration in the lung, routine light microscopic examination resulting in a semiquantitative morphological index (SMI) of lung injury, and quantitative morphological measurements (fibrosis fraction and alveolar wall area fraction) aided by optimas image analysis software. Changes in BAL fluid attributed to bleomycin treatment include increased total cell count (days 14 and 21), and increased percentage of neutrophils (days 3 and 6) followed by a sustained increase in lymphocytes (days 6, 14 and 21). Hydroxyproline levels increased in bleomycin-treated mice on days 14 and 21. Median SMI grades were significantly elevated on days 3, 14 and 21. Computer-assisted morphometry demonstrated a 3-fold increase in fibrosis fraction and a 1.3-fold increase in wall area fraction in bleomycin-treated mice on day 14, with no further increase on day 21. These data also demonstrate that the most suitable time point for assessing lung fibrosis in this model is 14 days after IT instillation of bleomycin, based on the observation that at 14 days the animals developed extensive fibrosis, but had less variability in the fibrotic response and lower mortality than later at 21 days. Computer-assisted morphometry provides objective and quantitative measurements that are a useful tool for the evaluation of bleomycin-induced lung injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383190      PMCID: PMC2517673          DOI: 10.1046/j.1365-2613.2002.00220.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  39 in total

1.  Class II antigens of the major histocompatibility complex are increased in lungs of bleomycin-treated rats.

Authors:  D Struhar; J Greif; R J Harbeck
Journal:  Immunol Lett       Date:  1990-11       Impact factor: 3.685

Review 2.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

3.  The effect of suramin on bleomycin-induced lung injury.

Authors:  I S Lossos; G Izbicki; R Or; R H Goldstein; R Breuer
Journal:  Life Sci       Date:  2000-10-27       Impact factor: 5.037

4.  Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis.

Authors:  N Dobashi; J Fujita; M Murota; Y Ohtsuki; I Yamadori; T Yoshinouchi; R Ueda; S Bandoh; T Kamei; M Nishioka; T Ishida; J Takahara
Journal:  Lung       Date:  2000       Impact factor: 2.584

5.  The effect of enoxaparin on bleomycin-induced lung injury in mice.

Authors:  U Laxer; I S Lossos; S Gillis; R Or; T G Christensen; R H Goldstein; R Breuer
Journal:  Exp Lung Res       Date:  1999-09       Impact factor: 2.459

6.  Circulating cytokeratin 8:anti-cytokeratin 8 antibody immune complexes in sera of patients with pulmonary fibrosis.

Authors:  N Dobashi; J Fujita; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Kamei; M Tokuda; S Hojo; S Bandou; Y Ueda; J Takahara
Journal:  Respiration       Date:  2000       Impact factor: 3.580

7.  Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis.

Authors:  R E Swiderski; J E Dencoff; C S Floerchinger; S D Shapiro; G W Hunninghake
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

8.  Effect of immunomodulators on bleomycin-induced lung injury.

Authors:  S Kremer; R Breuer; I S Lossos; N Berkman; T G Christensen; M W Connor; R H Goldstein; R Or
Journal:  Respiration       Date:  1999       Impact factor: 3.580

9.  Superoxide anion production by rat neutrophils at various stages of bleomycin-induced lung injury.

Authors:  E B Tarnell; B L Oliver; G M Johnson; F L Watts; R S Thrall
Journal:  Lung       Date:  1992       Impact factor: 2.584

10.  The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury.

Authors:  S K Sharma; J A MacLean; C Pinto; R L Kradin
Journal:  Am J Respir Crit Care Med       Date:  1996-07       Impact factor: 21.405

View more
  137 in total

1.  A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.

Authors:  J S Swaney; C Chapman; L D Correa; K J Stebbins; R A Bundey; P C Prodanovich; P Fagan; C S Baccei; A M Santini; J H Hutchinson; T J Seiders; T A Parr; P Prasit; J F Evans; D S Lorrain
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion.

Authors:  Neil Ahluwalia; Paula E Grasberger; Brian M Mugo; Carol Feghali-Bostwick; Annie Pardo; Moisés Selman; David Lagares; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

Review 3.  Stem cells in the lung.

Authors:  Xiaoming Liu; Ryan R Driskell; John F Engelhardt
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

4.  Effects of erdosteine on bleomycin-induced lung fibrosis in rats.

Authors:  Haşim Boyaci; Hale Maral; Gupse Turan; Ilknur Başyiğit; Meltem O Dillioğlugil; Füsun Yildiz; Melih Tugay; Ayşe Pala; Cengiz Erçin
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

5.  Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.

Authors:  Keren Borensztajn; Paul Bresser; Chris van der Loos; Ilze Bot; Bernt van den Blink; Michael A den Bakker; Joost Daalhuisen; Angelique P Groot; Maikel P Peppelenbosch; Jan H von der Thüsen; C Arnold Spek
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

6.  Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3-/-) mice.

Authors:  Tejas R Karhadkar; Wensheng Chen; Richard H Gomer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

7.  Role of α1 and α2 chains of type IV collagen in early fibrotic lesions of idiopathic interstitial pneumonias and migration of lung fibroblasts.

Authors:  Hirokazu Urushiyama; Yasuhiro Terasaki; Shinya Nagasaka; Mika Terasaki; Shinobu Kunugi; Takahide Nagase; Yuh Fukuda; Akira Shimizu
Journal:  Lab Invest       Date:  2015-05-25       Impact factor: 5.662

8.  Genetic susceptibility to toxicologic lung responses among inbred mouse strains following exposure to carbon nanotubes and profiling of underlying gene networks.

Authors:  Evan A Frank; Vinicius S Carreira; Kumar Shanmukhappa; Mario Medvedovic; Daniel R Prows; Jagjit S Yadav
Journal:  Toxicol Appl Pharmacol       Date:  2017-04-19       Impact factor: 4.219

9.  Fatty acid nitroalkenes inhibit the inflammatory response to bleomycin-mediated lung injury.

Authors:  Melissa L Wilkinson; Elena Abramova; Changjiang Guo; James G Gow; Alexa Murray; Adolf Koudelka; Veronika Cechova; Bruce A Freeman; Andrew J Gow
Journal:  Toxicol Appl Pharmacol       Date:  2020-09-12       Impact factor: 4.219

10.  A micro-CT analysis of murine lung recruitment in bleomycin-induced lung injury.

Authors:  Scott Shofer; Cristian Badea; Yi Qi; Erin Potts; W Michael Foster; G Allan Johnson
Journal:  J Appl Physiol (1985)       Date:  2008-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.